YENİ VE YENİDEN TANIMLANAN ENFEKSİYONLAR VE ENFEKSİYON KONTROLÜ II 21.YÜZYILDA YENİDEN TANIMLANAN ENFEKSİYONLAR VE ENFEKSİYON KONTROLÜ

Yeni ya da yeniden görülmeye başlayan hastalıklar, ilk kez tanımlanan veya görülme sıklıkları, aralıkları ve özellikleri hızlı biçimde artmakta olan enfeksiyonlardır. Mikroplar ve konakçıları arasındaki ilişki, bu ilişkinin meydana geldiği çevre tarafından etkilenmekte, ilişkinin dengesi değişmekte ve devamlı evrim geçirmektedir. Bu dinamik etkileşim hem enfeksiyon hastalıklarının yarattığı tehditlerin doğasını etkilemekte, yeni enfeksiyonların gelişmesine katkıda bulunmaktadır. Makalenin bu ikinci bölümünde 21. yüzyılda yeni ortaya çıkan ya da önceden bilindiği halde görülüş özelliklerinde değişimler olduğu tanımlanan enfeksiyon hastalıklarından KırımKongo Kanamalı Ateş KKKA , Kuş gribi Avian influenza , Domuz gribi Swine influenza , Şiddetli Akut Solunum Yolu Sendromu Severe Acute Respiratory Syndrome-SARS hasalıklarının tarihi gelişimi, etken virüsün özellikleri, hastalığın epidemiyolojisi, bulaş yolları, inkübasyon süresi, tanı kriterleri, belirti ve bulguları, tedavisi, enfeksiyon kontrolü ve bu enfeksiyonların kontrolünde hemşirenin rolü ele alınmaktadır

Anahtar Kelimeler:

Enfeksiyon, yeni tanımlanan enfeksiyon, enfeksiyon kontrolü, domuz gribi, H1N1 gribi, kuş gribi, SARS, Kırım Kongo Kanamalı Ateş, KKKA, enfeksiyon kontrolü

EMERGING AND REEMERGING INFECTIONS AND INFECTION CONTROL II REEMERGING INFECTIONS IN 21ST CENTURY

Emerging and reemerging diseases are infections that have defined the first time or their incidence has rapidly increased and their view properties/characteristics have rapidly changed. Relationship between microbes/germs and their hosts are influenced by environment in which this relationship consists, change the balance of the relationship and are constantly evolving. This dynamic interaction both affects the nature of the threat of infectious diseases and contributes to the development of the newly recognized infections. In this second part of the article was composed in two parts was handled some characteristic and reasons of the infections especially emerging or although previously known but changes in the properties were described and called as reemerging in 21 century are discussed. A short information about the historical and epidemiologic characteristics, sign and symptoms, treatments infections control measures of Crimean Congo Hemorrhagic Fever, Avian influenza, Swine flu Influenza AH1N1 flu , Severe Acute Respiratory Syndrome are briefed. The roles of nurses in the protection and control of these infections are discussed

Keywords:

Infection, emerging infection, reemerging infection, infection control, swine flu, H1N1 flue, Crimean Congo Hemorrhagic Fever, Avian influenza, Severe Acute Respiratory Syndrome,

PDF

___

Acar A, Beşirbellioğlu B (2005). Kuş Gribi (Avian Influenza). TSK Koruyucu Hekimlik Bülteni, 4 (6): 345-353.
Akan M (2007). Kümes Hayvanlarında Kuş Gribi, Flora, 12(1):14-21.
Alexander DJ (2008). Avian Influenza – Diagnosis, Zoonoses and Public Health 55 : 16–23.
Badur S (2007). İnsanlarda Kuş Gribi Tanısı. Flora, 12(1): 22-25.
Badur S (2010a). Pandemik influenza A (H1N1) 2009 epidemiyolojisi. Türk Pediatri Arşivi. 45: 80. Yıl: 25-30.
Badur S (2010b). H1N1 Epidemiyolojisi ve Virüs. ANKEM Dergisi 24(Ek 2):190-195.
Bettinger JA, Sauve LJ, Scheifele DW ve ark. (2010). Pandemic influenza in Canadian children: A summary of hospitalized pediatric cases. Vaccine, 28(18): 3180-3184.
Bozkurt GY, Memikoğlu O, Azap A ve ark. (2005). Kırım Kongo Kanamalı Ateşi: Olgu Sunumu, Ankara Üniversitesi Tıp Fakültesi Mecmuası, 58 (4): 193-196.
Cengiz AB (2010). Pandemik H1N1 influenza: Çocuklarda klinik bulgular, tanı ve tedavi. Hacettepe Tıp Dergisi 41:28-37.
Centers for Disease Control and Prevention (CDC)(2004). In the Absence of SARS-CoV Transmission Worldwide: Guidance for Surveillance, Clinical and Laboratory Evaluation, and Reporting Version Accessed date: 21.01.2004. Available from http://www.cdc.gov/ncidod/sars/pdf/absenceofsars.pdf
Centers for Disease Control and Prevention (CDC)(2008). Avian Influenza A Virus Infections of Humans; Accessed date: 20.06.2010. Available from http://www.cdc.gov/flu/avian/gen-info/avian-flu-humans.htm.
Centers for Disease Control and Prevention (CDC)( 2009a). Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 season. Atlanta, GA: Centers for Disease Control and Prevention; Accessed date: 10.03.2010. Available from: http://www.cdc.gov/h1n1flu/ recommendations.html
Centers for Disease Control and Prevention (CDC)(2009b). Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel. Atlanta, GA: Centers for Disease Control and Prevention; Accessed date: 10.02.2010. Available from: http://www.cdc.gov/ h1n1flu/guidelines_infection_control.htm
Centers for Disease Control and Prevention (CDC)(2009c). Interim guidance for infection control for care of patients with confirmed or suspected novel influenza A (H1N1) virus infection in a health-care setting. Atlanta, GA: Centers for Disease Control and Prevention; Accessed date: 10.02.2010. Available from http://www.cdc.gov/h1n1flu/ guidelines_infection_ control. html.
Centers for Disease Control and Prevention (CDC)(2009d). Interim Guidance on Specimen Collection, Processing, and Testing for Patients with Suspected Novel Influenza A (H1N1) Virus Infection. Atlanta, GA: Centers for Disease Control and Prevention; Accessed date: 10.02.2010. Available from http:// www.cdc.gov/swineflu/specimencollection.htm
Chandrakant SR, Gharge DS, Salve PL ve ark. (2009) Swine influenza (H1N1 FLU / Journal of Pharmacy Research 2009, 2(11),1678-1684
Ciblak MA, Albayrak N, Odabafl ve ark. (2009). Cases of influenza A (H1N1) reported in Turkey, May-July 2009. http://www.eurosurveillance.org/images/dynamic/EE/V14N32/art19304.pdf
Crowcroft N, Morgan D, Brown DW (2002).Viral haemorrhagic fevers in Europe- Effective control requires a co-ordinated response. Europe Surveillance 7(3): 343.
Del Rıo C ve Guarner J (2010). The 2009 influenza A (H1N1) Pandemic: What have we learned in the past 6 months. Transactıons Of The Amerıcan Clinical And Climatological Association, 121: 128-137.
Drosten C, Gottig S, Schilling S ve ark. (2002). Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. Jounaş Clinical Microbiology, 40: 2323- 2330.
Eisenberg JNS, Desai MA, Levy K ve ark.(2007). Enviromental determinants of infectious disease: A framework for tracking causal links and guiding public health research, Environ Health Perspect, 115(8):1216-23.
Elaldı N (2004). Kırım-Kongo Hemorajik Ateş Epidemiyolojisi, Cumhuriyet. Üniversitesi Tıp Fakültesi Dergisi, 26(4):185-190
Embree J (2010). Pandemic 2009 (A)H1N1 influenza (swine flu)-the Manitoba experience Biochem. Cell Biology, 88: 589–593.
Fauci AS (2005). Emerging and remerging infectious diseases: The perpetual challenge, Academic Medicine; 80(12):1079-05.
Girard MP, Tam JS, Kieny MP (2010). The 2009 A (H1N1) influenza virus pandemic: A review, Vaccine 28: 4895–4902.
Goldrick BA (2004). 21st-Century Emerging and Reemerging Infections. American Journal of Nursing, January. 104 (1): 67-70.
Hoa G ve Parker J (2006). Avian influenza: risk, preparedness and the roles of public health nurses in Hong Kong, Nursing Inquiry, 13(1): 2–6
Kanra G ve Kara A (2003). SARS: şiddetli akut solunum yetmezliği sendromu. Çocuk Sağlığı ve Hastalıkları Dergisi, 46: 155-161.
Kara A (2006). Kırım Kongo hemorajik ateşi. Çocuk Sağlığı ve Hastalıkları Dergisi, 49(3):175-184.
Ka-Wai HE (2006). Reasons for the increase in emerging and re-emerging viral infectious diseases. Microbes and Infection, 8:905-916.
Lashley FR (2006). Emerging infectious diseases at the beginning of the 21st century, Online Journal of Issues Nursing, 11(1):2.
Louria DB (2000). Emerging and re-emerging infections: The societal determinants, Futures 32: 581–594
Ma W ve Richt JA (2011). Swine influenza vaccines: current status and future perspectives. Animal Health Research Reviews 11(1):81–96.
Melville DS ve Shortridge KF (2006). Spread of H5N1 avian influenza virus: an ecological conundrum, The Society for Applied Microbiology, 42: 435–437.
Neumann G, Noda T, Kawaoka Y (2009). Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature, 459(7249): 931–939.
Özdemir D ve Şencan İ (2002).Güncel Bilgilerle SARS. Düzce Tıp Fakültesi Dergisi, 4 (2): 34-38.
Spika JS ve Butler-Jones D (2009). Pandemic influenza (H1N1): our Canadian response. Canadian Journal of Public Health, 100(5): 337–339.
T.C.Sağlık Bakanlığı (2005a). Temel Sağlık Hizmetleri Genel Müdürlüğü Kırım-Kongo Kanamalı Ateşi Kitabı Ankara.
T.C. Sağlık Bakanlığı (2005b) Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı ve Temel Sağlık Hizmetleri Genel Müdürlüğü Aylık Epidemiyoloji Raporu Avian İnfluenza (Kuş Gribi) Nedir? 4 (6): 162-164
T.C. Sağlık Bakanlığı (2009) Pandemik (H1N1) 2009 Gribi Klinik Vaka Yönetimi (25 Kasım 2009). Erişim tarihi: 18.01. 2011. http://www.grip.saglik.gov.tr
T.C. Sağlık Bakanlığı. (2010a). Kırık Kongo Kanamaları Ateşi (KKKA)’nde alınacak kontrol önlemleri. Erişim tarihi: 02.06.2010 http://www.saglik.gov.tr/KKKA/belge/1-6588/kirim-kongo-kanamali-atesinden- korunmada-ve-hastaligin-.html
T.C. Sağlık Bakanlığı (2010b). Avian İnfluenza: Pandemi Değerlendirmesi ve Sağlık Bakanlığının Bu Konuda Yaptığı Çalışmalar. Erişim Tarihi: 20.07.2010 http://www.saglik.gov.tr/extras/birimler/temel/ pandemi_degerlendirme.pdf.
Türk Toraks Derneği (2010) SARS. Erişim Tarihi: 10.06.2010 http://www.toraks.org.tr/news.php?id=81
World Health Organization (WHO)(2006) Crimean-Congo haemorrhagic fever (CCHF). Accessed date: 06.06.2010.http://www.who.int/csr/disease/crimean_congoHF
World Health Organization (WHO) (2007). World Health Report 2007 - A Safer Future: Global Public Health Security in the 21st Century.
World Health Organization (WHO) (2009 a). WHO Current WHO phase of pandemic alert for Pandemic (H1N1) 2009 Accessed date: 10.02.2010. Available from http://www.who.int/csr/disease/swineflu/ phase/ en/index.html
World Health Organization (WHO) (2009b). Pandemic (H1N1) 2009 Accessed date: 10.02.2010. Available from http://www.who.int/csr/disease/swineflu/en/index.html
World Health Organization (WHO) (2009c). Global surveillance during an influenza pandemic. WHO. Accessed date: 10.02.2010. Available from http://www.who.int/csr/resources/publications /swineflu/surveillance/ en/index.html
World Health Organization (WHO)(2009d). WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Geneva, Switz: World Health Organization; 2009. Accessed date: 16.01.2010. Available from: http://www.who.int/csr/resources/publications/ swineflu/h1n1- use-antivirals-20090820/en/index. html
World Health Organization (WHO)(2010). Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO; Accessed date: 20.07.2010. Available from http://www.who.int/csr/disease/avian_influenza/country/cases_table_2010_06_08/en/index.html.
Yılmaz GR, Çevik MA, Ünal S (2007). Avian İnfluenza: Epidemiyoloji, Patogenez, Klinik Özellikler ve Tedavi. Flora, 12(1): 26-45.